Patent · US Expired

Antibodies that bind to endoglin

US5660827A · kind A · utility

130Cited by
4References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 1995
Grant dateAug 26, 1997
Priority date
Expiry dateJun 1, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are antibodies that specifically bind to endoglin. Conjugates of the antibodies linked to diagnostic or therapeutic agents are also provided. Methods of using the antibodies and conjugates are also disclosed, including methods of targeting the vasculature of solid tumors through recognition of the tumor vasculature-associated antigen, endoglin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.